These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16482461)

  • 41. All nations depend on the global knowledge pool--analysis of country of origin of studies used for health technology assessments in Germany.
    Herrmann KH; Wolff R; Scheibler F; Waffenschmidt S; Hemkens LG; Sauerland S; Antes G
    PLoS One; 2013; 8(3):e59213. PubMed ID: 23516611
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Health technology assessment and the regulation of medical devices and procedures in Quebec. Synergy, collusion, or collision?
    Battista RN; Lance JM; Lehoux P; Régnier G
    Int J Technol Assess Health Care; 1999; 15(3):593-601. PubMed ID: 10874385
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Guidance for future HTA applications to vaccines: the HPV lesson.
    La Torre G; de Waure C; Chiaradia G; Mannocci A; Capri S; Bamfi F; Ricciardi W
    Hum Vaccin; 2011 Sep; 7(9):900-4. PubMed ID: 21865880
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Washington taps into healthcare technology.
    Abrahamsen C
    Nurs Manage; 2005 Mar; 36(3):52-5. PubMed ID: 15764993
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Health technology assessment from a Canadian device industry perspective.
    Ferrusi IL; Ames D; Lim ME; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):353-9. PubMed ID: 19394576
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Institute for Quality and Efficiency in Health Care: Germany.
    Nasser M; Sawicki P
    Issue Brief (Commonw Fund); 2009 Jul; 57():1-12. PubMed ID: 19639711
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Information on legal issues in health technologies: methodological proposal to identify them in a systematic and comprehensible manner].
    Droste S; Rixen S
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(7):509-22. PubMed ID: 22981028
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reflections on the evolution of health technology assessment in Europe.
    Sorenson C; Chalkidou K
    Health Econ Policy Law; 2012 Jan; 7(1):25-45. PubMed ID: 22221927
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Points of view: the role of quality measurement from the Federal Joint Committee's perspective].
    Klakow-Franck R
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(8-9):456-64. PubMed ID: 25523843
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hospital-based technology assessment programmes: two Canadian examples.
    Juzwishin D; Olmstead D; Menon D
    World Hosp Health Serv; 1996; 32(2):2-9. PubMed ID: 10165872
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HTA of medical devices: Challenges and ideas for the future from a European perspective.
    Fuchs S; Olberg B; Panteli D; Perleth M; Busse R
    Health Policy; 2017 Mar; 121(3):215-229. PubMed ID: 27751533
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methods, procedures, and contextual characteristics of health technology assessment and health policy decision making: comparison of health technology assessment agencies in Germany, United Kingdom, France, and Sweden.
    Schwarzer R; Siebert U
    Int J Technol Assess Health Care; 2009 Jul; 25(3):305-14. PubMed ID: 19619349
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HEALTH TECHNOLOGY ASSESSMENT IN SERBIA.
    Atanasijevic D; Zah V
    Int J Technol Assess Health Care; 2017 Jan; 33(3):384-389. PubMed ID: 28662733
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Health technology assessment in South Korea.
    Kim CY
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():219-23. PubMed ID: 19527540
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Testing a new taxonomic model for the assessment of medical devices: Is it plausible and applicable? Insights from HTA reports and interviews with HTA institutions in Europe.
    Fuchs S; Olberg B; Perleth M; Busse R; Panteli D
    Health Policy; 2019 Feb; 123(2):173-181. PubMed ID: 29703653
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Using health technology assessment to identify gaps in evidence and inform study design for comparative effectiveness research.
    Tunis SR; Turkelson C
    J Clin Oncol; 2012 Dec; 30(34):4256-61. PubMed ID: 23071248
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evidence-Based Decision Making 3: Health Technology Assessment.
    O'Reilly D; Audas R; Campbell K; Vanstone M; Bowen JM; Schwartz L; Assasi N; Goeree R
    Methods Mol Biol; 2021; 2249():429-454. PubMed ID: 33871857
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Health technology assessment in the international context: where does Germany stand? For the "German Scientific Working Group Technology Assessment for Health care"].
    Bitzer EM; Busse R; Kohlmann T; Lühmann D; Perleth M
    Z Arztl Fortbild Qualitatssich; 1999 Jan; 93(1):33-8. PubMed ID: 10198976
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diffusion and use of health technology assessment in policy making: what lessons for decentralised healthcare systems?
    Ciani O; Tarricone R; Torbica A
    Health Policy; 2012 Dec; 108(2-3):194-202. PubMed ID: 23093020
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Health technology assessment in Germany. Status, challenges, and development.
    Perleth M; Busse R
    Int J Technol Assess Health Care; 2000; 16(2):412-28. PubMed ID: 10932416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.